iX Biopharma Ltd announced the allotment and issuance of 2.39 million new ordinary shares on Jun, 24 2026 after investors exercised warrants at an exercise price of 0.06 Singapore dollars per share.

The new shares boosted the company’s issued share capital from 1.06 billion to 1.06 billion shares and will begin trading on the Singapore Exchange around Jun, 26 2026.

To date, 27.61 million warrants, representing 48.01% of the total issued, have been exercised, leaving 29.90 million warrants outstanding. These remaining warrants, also priced at 0.06 Singapore dollars each, will expire at 5:00 p.m. on Jul, 17 2026.

The final trading day for the warrants is set for Jul, 10 2026, with delisting scheduled for Jul, 20 2026. Any unexercised warrants after the expiration deadline will lapse and become void.